- 12 oral surgery updates in 2026
- 5 ASC, MOB deals in California
- Hidden OR capacity challenges: 8 perioperative leaders on what’s draining surgical time
- The Aspen Group’s 3-year growth recap: 40 moves
- Florida State University set to acquire Tallahassee hospital
- How Confusing Financial Journeys Undermine Revenue and Trust
- How Confusing Financial Journeys Undermine Revenue and Trust
- Misalignment, Not Malice: Rethinking Generational Conflict in Healthcare
- If AI ‘adds friction, it fails’: How Mayo Clinic scales technology
- As maternity units close, AdventHealth restores OB care in rural Kansas
- Oklahoma officials warn of new opioid
- The new metrics of healthcare technology ROI: What matters to healthcare leaders
- Hoag to launch transplant center in 2027
- MercyOne hospital to transition labor and delivery services
- MercyOne hospital to transition labor and delivery services
- Southeast metros lead US population growth as national gains slow
- 8 Medicare Advantage numbers to know in 2026
- 17 Senate Dems push back on 2027 ACA proposal
- Providence hospital closes inpatient pediatric unit
- Michigan finalizes Medicaid mental health assessment policy changes
- 10 financial notes on USPI’s growth over the past 3 years
- 15 new orthopedic practice, center openings in Q1
- The oral surgery technological revolution
- From Anxiety to Action: How Ambulatory Leaders Are Rebuilding Margins in 2026
- Where GI training may fall short
- What it took to become the world’s first ASC to offer Stryker’s robotic knee tech
- Medtronic’s win in spinal cord stimulator lawsuit upheld
- How the Trump Administration Uses Migrant Kids To Find and Detain Family Members
- Heartland Dental’s 3-year growth recap: 30+ moves
- Cencora’s $10B+ physician acquisition spree: A breakdown
- Tennessee physician practice acquired
- The FTC is coming for healthcare consolidation: 10 things physicians need to know
- Adventist Health sees momentum from insourcing revenue cycle operations
- Oral GLP-1s, COVID preventatives: 3 more drugs in the pipeline, Optum says payers should watch
- Unlicensed dentistry cases, DSO deals, legislation & more: 10 dentistry updates in Virginia
- Missouri system debuts mobile behavioral health unit
- Yale researchers study GLP-1’s potential for SUD
- Texas dental school receives $6.5M to expand pediatric dental, medical programs
- North Carolina autism provider to expand therapy access
- $3M Verdict Links Social Media to Anxiety and Depression
- West Virginia hospital to end OB delivery services
- 6 DSOs making headlines
- California hospital’s finances improve, cash position remains ‘dire’
- 1 in 5 metro markets face inpatient monopoly: 7 notes
- Minnesota system faces uncertainty amid Medicare delays
- Ohio county approves behavioral health crisis center plan
- The White House Delays CDC Pick
- New COVID 'Cicada' Variant Is Spreading — What Experts Want You To Know
- Op-ed: Empathy meets efficiency—how the responsible use of AI can transform Medicare
- Family Caregivers Provide $1 Trillion In Annual Labor, AARP Says
- ‘Health Doesn’t Need to Be Ludacris’: Bayer signs rapper-actor to multivitamin campaign
- Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
- Healthy Lab Results May Mask Future Risks for Kids with Obesity
- At-Home Chemotherapy Is Safe, Feasible, Pilot Study Indicates
- What You Do While Sitting Could Predict Dementia Risk
- New Cholesterol Guidelines: What Patients and Caregivers Need to Know
- Want A Bootlicking Yes Man? Ask An AI Chatbot For Advice, Study Warns
- Specially Coated Implants Better For Breast Cancer Patients, Study Finds
- Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
- Give and Take: Federal Rural Health Funding Could Trigger Service Cuts
- Fierce Pharma Asia—Takeda’s $1.3B reorg; India’s GLP-1 floodgates; Gilead’s $2.2B buy of a China NewCo
- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Why private practice dentistry needs a better model
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Nonprofit highlights rural opioid care strategies
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- What the Health? From KFF Health News: A Headless CDC
- 20 behavioral health leaders challenge industry assumptions
- Recordati confirms it's weighing CVC Capital buyout offer of $12.6B
- 3 California behavioral health centers to close amid funding shifts
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- SCAN taps biopharma, CMS vet Aman Bhandari as its first chief AI officer
- Infosys to acquire Optimum Healthcare IT in $465M deal
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- Remarks at the Financial Stability Oversight Council Meeting
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- New therapy animal program aims to support 100K patients, providers
- Pulse check on Lilly's GLP-1 fortunes
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
COVID seemed proof enough that freedom of speech leads to better healthcare options. Maybe that's just me - and at least one judge.
The Daily Signal shows Twitter and court order images at the link.
Tyler O'Neil / @Tyler2ONeil / July 05, 2023
On the Fourth of July, a federal judge condemned the Biden administration’s collusion with Big Tech companies to suppress Americans’ free speech as “similar to an Orwellian ‘Ministry of Truth’” and issued a historic order temporarily blocking the federal government from pressuring tech companies to stifle speech.
“It is fitting that the judge granted a first-of-its-kind injunction on the Fourth of July because that day paved the way for our country to adopt the First Amendment,” Missouri Attorney General Andrew Bailey, a Republican, told The Daily Signal in a statement Wednesday. “We had to fight the Revolutionary War in part because King George tried to stamp out political dissent. Now, the Biden administration is trying to censor speech he disagrees with. Fortunately, and thanks to the brave Founders on the Fourth of July, we now have the First Amendment to push back against the Biden administration’s censorship regime.”
“It could not be more perfect timing,” Louisiana Solicitor General Liz Murrill, a Republican, told The Daily Signal in a phone interview Wednesday. “I can’t ever recall such a sprawling government enterprise to censor American speech being unraveled in this manner.”
Bailey and Murrill are leading the case Missouri v. Biden, and they celebrated Judge Terry Doughty’s ruling in U.S. District Court for the Western District of Louisiana on Tuesday.
“During the COVID-19 pandemic, a period perhaps best characterized by widespread doubt and uncertainty, the United States government seems to have assumed a role similar to an Orwellian ‘Ministry of Truth,’” Doughty wrote. His ruling included a preliminary injunction, barring federal officials from colluding with Big Tech companies to suppress free speech.
Gene Hamilton, vice president of America First Legal, which represents two plaintiffs in the case against the Biden administration, told The Daily Signal he did not consider it a “coincidence” that Doughty issued the order on July Fourth.
“It’s a monumental decision for the American people—a great day for all Americans,” Hamilton said in a phone interview Wednesday. “It was a great, great Fourth of July.”
“It was only appropriate for this decision to be rendered on Independence Day,” he added. “It’s a reaffirmation of our enduring principles on which our country was founded.”
“The Biden administration has made combating ‘mis-,’ ‘dis-,’ and ‘malinformation’ a high priority,” Hamilton added. “They appear to view it as a systemic threat to the existence of democracy when nothing could be further from the truth. The solution to ‘mis-’ and ‘disinformation’ and false information is simply the truth and more information, and letting people draw their own conclusions.”
The lawyer also said he had never heard of another judge issuing an injunction to prevent the federal government from directing Big Tech to suppress speech online.
Doughty’s ruling notes that the plaintiffs in the case—Missouri and Louisiana, represented by Bailey and Murrill; doctors who spoke out against the COVID-19 mandates, such as Martin Kulldorff, Jayanta Bhattacharya, and Aaron Kheriaty; Gateway Pundit founder Jim Hoft; and anti-lockdown advocate and Health Freedom Louisiana Co-Director Jill Hines—allege that the Biden administration “suppressed conservative-leaning free speech” on the Hunter Biden laptop story ahead of the 2020 presidential election; on COVID-19 issues, including its origin, masks, lockdowns, and vaccines; on election integrity in the 2020 presidential election; on the security of voting by mail; on the economy; and on President Joe Biden himself.
Doughty’s injunction names various federal agencies—including the Department of Health and Human Services, the National Institute of Allergy and Infectious Diseases (the agency Dr. Anthony Fauci formerly directed), the Centers for Disease Control and Prevention, the FBI, the Department of Justice, and the State Department—and officials, including HHS Secretary Xavier Becerra, Surgeon General Vivek Murthy, and White House press secretary Karine Jean-Pierre.
It forbids those people and agencies from “meeting with social media companies for the purpose of urging, encouraging, pressuring, or inducing in any manner the removal, deletion, suppression, or reduction of content containing protected free speech posted on social-media platforms”; from flagging posts for removal or suppression; from encouraging censorship; and from contacting Big Tech companies via email, phone, or letters for such purposes.
It also specifically bars collaboration with third-party organizations aiming at urging social media companies to suppress forms of speech. It also bars the Biden administration from notifying Big Tech firms to “be on the lookout” for posts containing protected free speech.
The injunction does not restrict government agencies from all collaboration with Big Tech companies, however. It does not prohibit agencies from flagging posts involving criminal activity, or from notifying them of national security threats, malicious cyber activity, or criminal efforts to suppress voting or influence elections. It also expressly allows the administration to post “permissible public government speech” online.
Hamilton, the America First Legal attorney whose firm represents Hoft and Hines, argued that the injunction’s carve-outs for specific government interaction with Big Tech firms would return the relationship to the status quo before the Biden administration.
“There’s no First Amendment right to engage in criminal conduct,” he noted. “It’s still totally fine for the government to point out to a social media company, ‘It turns out you have some child porn from this user,’ or that there’s a drug trafficker using your platform to communicate.”
“Those are natural functions of government,” Hamilton explained. “Most folks would understand this is the role that the government used to play with social media companies online” before the Biden administration weaponized it.
The judge’s order does not represent a complete win for the defendants, however. It denies plaintiffs a “class determination,” which would have included far more people in the lawsuit.
“It was unfortunate that he didn’t certify a class,” Murrill, the solicitor general of Louisiana, told The Daily Signal. “I think that part of the ruling is disappointing.”
Both Hamilton and Murrill predicted that the Biden administration will file a motion to “stay” the injunction, likely followed by an appeal to the 5th U.S. Circuit Court of Appeals.
Murrill also condemned the censorship “enterprise” the Biden administration set up. She likened it to the government’s targeted silencing of people loosely associated with the Communist Party under Sen. Joe McCarthy, R-Wis., in the 1950s.
“Here, you basically see a similar enterprise being set up, targeting predominantly conservative speech, but the enterprise doesn’t know political boundaries,” she warned. “Once the structure’s in place, the structure can be weaponized by anybody in power.”
“It turns the Constitution on its head,” Murrill declared. “It flagrantly violates the First Amendment rights of everyone in this country.” She further noted that when Americans challenge the Biden administration on this, “their answer is not to pull back on violating people’s rights; it’s to defend the enterprise. It’s to double down on speech as dangerous.”
The solicitor general cited Jen Easterly, the director of the Cybersecurity and Infrastructure Security Agency, who called it “really, really dangerous if people get to pick their own facts.”
“So, in her view, government needs to pick those facts for us,” Murrill said. “It ought to shock everyone’s conscience that they’re so willing to unapologetically violate our constitutional rights and then turn around and tell us it’s good for us, that they know better.”
She emphasized that the federal government circumvented “that pesky First Amendment” by making Big Tech companies “agents of the government.”
The White House did not respond to The Daily Signal’s request for comment by publication time.
Bhattacharya, the doctor who opposed COVID-19 lockdowns and led the Great Barrington Declaration, found himself on a Twitter Trends blacklist for his medical guidance on combating the pandemic. As evidence of government collusion with Twitter came out in the Twitter Files, Bhattacharya wrote, “I learned in a very concrete and painful way the effects of Washington and Silicon Valley working together to marginalize unpopular ideas and people to create an illusion of consensus.”
In January, as part of this lawsuit, Bailey, the Missouri attorney general, unearthed documents in which Facebook told the White House that it suppressed “often-true content” that might discourage Americans from taking COVID-19 vaccines.
On the 2020 election, Doughty wrote that Easterly’s Cybersecurity and Infrastructure Security Agency and the third-party Election Integrity Partnership are “completely intertwined.” The Election Integrity Partnership reported “misinformation” to social media platforms, helping the federal government pressure Big Tech to silence speech.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















